Our Network of Consultants

Senior executive and consultant in Life Sciences focused on applying precision diagnostics to liquid biopsies to ascertain the molecular profile of single or multiple cells captured and enriched from blood and cerebral spinal fluid.

Experience:
- Ph.D. in molecular genetics, 20 plus years biotechnology experience in R&D, technology and product development, project and operations management, leading to the design, development, manufacture and commercial launch of RUO products, CE marked, and FDA PMA and 510(k) cleared molecular diagnostic assays.
- Broad knowledge focused on state-of-the-art technologies for application in human and molecular genetics, molecular/immuno-diagnostics, and cell biology, directed toward advancing personalized medicine in rare gene disorder and complex diseases through precision diagnostics.
- Application of strategic and tactical operations to reduce timelines and meet multi-million dollar milestones for the successful launch of multiple products from concept to commercialization.
- Managed R&D, product development, and a P&L for a $230M cell culture business.
- Developed 1 and 5 year strategic road maps for new and mature products.
- High level of interpersonal skills managing multiple disciplines for innovative cross-functional projects, which include R&D, computational biology, phase-gate product development, business and market development, clinical studies, tech transfer to manufacturing for RUO and IVD products under design control, FDA QSR and ISO 13485:2016 compliance in cGMP environments.
- “Roll up sleeves” management style to motivate, lead and mentor individuals, in small and large teams, in multi-national matrix corporations, building organizations from the ground up, and meeting project timelines and financial milestones.
- Presentations to executive management, company boards, scientific meetings, investors and multiple publications in top scientific journals
- 10 issued patents and receipt of $4.4M in NIH grants.
- Broad network of key opinion leaders in human and infectious diseases leading to collaborations and partnerships.

Capabilities:
- Transition research companies and their technologies into product development power houses, converting research projects or Research Use Only (RUO) products for use as Laboratory Developed Tests (LDTs) or In-Vitro Diagnostic (IVD) medical devices.
- Develop end-to-end processes, from feasibility to validation via the IVD (510k or PMA) or LDT route for molecular and cellular diagnostic tests.
- Serve at the intersection of assessing technology in M&As.
- Generate focused strategy plans from Marketing (VOC) to Product Development of VOC generated diagnostic assays, to the transfer of developed assays, to Manufacturing/Operations for the manufacture of medical devices under ISO13485.

With over a decade of experience in Sales, Account Management, and Business Development across Europe, I bring a proven track record of growing revenue, structuring global sales operations, and managing complex biopharmaceutical relationships. My expertise spans both services and capital equipment (CAPEX) sales, with a consistent history of exceeding targets and closing multimillion-pound deals at executive level.

I currently operate as a Business Development and Sales Consultant for Cellevate AB and LiveDrop Bio, where I designed and implemented complete business development strategies, built CRM systems and performance dashboards, and positioned the companies among key academic and biopharma stakeholders. My recent achievements include generating leads and converting them into purchase orders through strong technical presentations and relationship-building with KOLs, CROs, and manufacturing partners.

Previously, as Global Key Account Manager at Miltenyi Biotec, I managed six global customers totaling 23 international sites, negotiated supply agreements, and developed multi-year growth strategies. I notably closed a £3.3 million CAPEX deal within two weeks and contributed €35 million toward the 2024 revenue plan. At Sartorius Stedim, I led high-value accounts across France, Benelux, and the UK, expanding revenue by more than 200% year-on-year while coordinating multi-site collaborations across R&D and manufacturing.

My career demonstrates a unique combination of scientific literacy and commercial strategy. I began in technical sales roles with Sartorius and BD, where I introduced innovative single-cell and flow cytometry technologies, managed market entry strategies, and won back blacklisted accounts through consultative negotiation. Over time, I transitioned into strategic sales leadership—defining go-to-market frameworks, establishing KPIs, and mentoring sales representatives across divisions and regions.

Fluent in both English and French, I excel in cross-cultural communication and high-level stakeholder engagement. My skill set spans consultative and strategic selling, global account mapping, contract negotiation, and profit planning. Equipped with deep knowledge of the biopharma value chain—from cell and gene therapy manufacturing to clinical and CDMO partnerships—I operate effectively within matrixed organizations and thrive in fast-evolving innovation environments.

Certified in advanced selling methodologies (Sandler, Miller Heiman, Mercuri) and completing PRINCE2 accreditation, I combine technical expertise, legal understanding, and business acumen to deliver sustainable commercial growth in the life sciences sector.

Strategic Product Management/Marketing Leader with 25+ years of experience in life sciences, specializing in product management, new product development, developing global marketing strategy within the IVD, oncology, and infectious disease markets. Extensive experience leading multifunctional teams, building stakeholder relationships, and launching products involving advanced technologies, including NGS.

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

As a Professor of Chemistry at King's College London and Group Leader at the Francis Crick Institute, following nine years at Oxford University where I was also a Royal Society University Research Fellow, I bring over 20 years of experience at the intersection of biophysics, chemistry, and nanotechnology. My research has pioneered novel approaches in membrane biophysics and single-molecule detection, leading to fundamental breakthroughs in nanopore sensing technology. I have developed four patented innovations in this field, with three successfully licensed to industry partners, including methods that enable five-order magnitude improvements in DNA sequencing throughput.

My expertise spans single-molecule microscopy, membrane protein biophysics, microfluidics, and the development of artificial cell membrane systems. I've developed particular specialization in membrane protein function, interferometric scattering microscopy, and optical single-channel recording, contributing to over 70 peer-reviewed publications. This work has been recognized with multiple honors including election as a Fellow of the Royal Society of Chemistry and the RSC Norman Heatley Award.

As a regular reviewer for leading journals including Science and Nature, I maintain active engagement with cutting-edge developments across biophysics and nanotechnology. I've held appointments at Oxford, Stanford, and Cambridge universities, building a broad international network in academia and industry. My experience includes serving as an invited nominator for the Chemistry Nobel Committee, consulting for biotechnology companies, and maintaining successful research collaborations with leading biotech partners.

My technical knowledge spans patent disputes, particularly those involving biophysics and nanopore sensing technologies, complemented by extensive experience in technology commercialization and independent technical review.

With over a decade's experience in Life Sciences, Biotechnology Commercialization and Law, I have developed a broad scope of skills in various fields, ranging from sales and marketing, to regulatory and logistic affairs. During my time as business developer, I assisted companies in establishing global distribution networks, raised global awareness through marketing campaigns, and increased sales revenue three-fold within 18 months. I have substantial experience in biotech commercialization and have successfully overseen the commercial release of more than 80 products into the global market.

I specialize in assisting companies to develop and expand their business in South Africa and other African countries. This process entails the development and implementation of a commercial strategy that is tailored for the specific territory of interest, as well as the establishment of customer and distributor networks, and guidance as to regulatory compliance and logistic considerations. I have an aptitude for relationship building, strategic planning and target customer profiling, which forms the foundation of my business development capabilities.

With more than 10 years of R&D experience in biochemistry and infection biology, I am a Senior Scientist for Surface Chemistry in Biotechnology at e-Proteins, the world leader in avidin derivatives production. I have been applying my expertise and skills to develop innovative binding protein solutions for diagnostic, biotech, and pharma industries, addressing the main challenges of streptavidin-based applications.

As a team leader and co-founder of Sapoto, I have also been managing and coordinating a team of 30 employees, integrating external service providers, and overseeing the quality management activities for other test centers. I hold the credentials of QMB Manager and Internal Auditor, which enable me to ensure compliance with GMP, GLP, and GCP standards. My mission is to contribute to the advancement of biotechnology and improve the quality and reliability of binding protein products.

Senior technical expertise on antibodies and immunoassays

With a thorough background of molecular cell biology and biochemistry, I have accrued multi-disciplinary knowledge and experience while working in both academic and commercial environments with an emphasis on antibodies and immunoassays. During my CSO appointment at an antibody manufacturer, I have gained global recognition on my knowledge of commercial antibodies and their validation through meetings and publications. During my time involving drugs discovery I have developed several assays and filed for patents. I have tutored and trained assistants to very high standard, and many of them have moved on the career ladder since then. After I have written SOPs in a GLP-audited CRO and many technical and managerial SOPs for a fast-growing research antibody manufacturer, my focus has been on protein biomarkers and antibody validation to industrial standard. This focus led to a thorough understanding of etiologies at protein level and of diagnostics and medical interventions. My understanding of physical, chemical, and pharmacological principles made me ready to move on as an independent consultant to aid antibody manufacturers and in vitro diagnostics industries. My interest in strategic planning has helped me thinking creatively thus providing valuable inspirations to move biotech/pharma companies forward.
Based on the above, I was in the opportunity to set up my own company to introduce a long sought after quality standard for commercial tool antibodies. This concept may ultimately also work for the early discovery of candidate therapeutic antibodies.
My expertise is now available to assist in technical or strategic hurdles when complementary experience is required. When assistance is needed for a start-up or for a well-established company, confidentiality is guaranteed, and NDAs can be exchanged when required.

30+ years of experience in the Life Sciences Industry, with particular expertise in research tools including antibodies, recombinant proteins and associated kits.
I have a PhD in Immunology, and commercial experience at Board level as Site Director, Commercial Director and Chairman. I have worked with family businesses, listed companies and PE backed companies, and have experience of developing companies to successful trade exits. My focus within industry has always been to identify new opportunities with either technology or with customers, and to execute those as quickly and effectively as possible.
Commercially I have gained in depth experience in a range of roles, and can offer advice in Business Development, Strategy, Operational and Technical areas My in-depth experience includes:-

Business Strategy
Reagent in-licensing and out-licensing
Supply agreements
Business development with major IVD and Pharmaceutical customers
Product development
P&L analysis and responsibility
Quality Systems
Developing and leading Commercial Sales and Marketing teams
Operational expertise and commercial reagent manufacturing

Having worked as a product and commercial manager for 18 years within the life science industry, my focus was always to identify cutting edge technology, applications and novel scientific companies, working with them to present their products to the wider research and IVD markets. With a skillset focused on bringing novel technologies to new markets and working to build diverse, integrated portfolios for platforms, my experience, combined with my scientific knowledge, placed me well to work within Mergers & Acquisitions on both buy side and sell side transactions along with strategic pieces.
Specialities: Biotech & Life science Consultancy, specialising in Business Development, strategy and M&A assistance.
Specialises in understanding how the scientific capabilities of companies can be presented to the life science customer base or utilised to build upon strengths of platforms for inorganic expansion.

40 years of experience working in the Research Tools industry, with focus on commercialization of Antibodies, Proteins and Assays. Have founded and ran my own businesses in the RUO area and successfully exited. Have also invested minority stakes in several RUO companies and sat on various Boards as an NED. Previously worked at Serotec for 25 years, then sat on Boards such as Innova Biosciences, Absolute Antibodies, Medix Biochemica, Cellexus & Oxford Expression Technologies.
Experience in setting up and implementing Distribution channels, marketing plans and full business plans. Helped companies exit.
Specialties: Biotech & Lifescience Consultancy, specialising in Business Development and M&A assistance.
Specialises in matching lifescience business partners (finding distributors & OEM Partners)